Investment panel discussion: Constructing the perfect biotech: how can the ATMP biotech industry attract European, US and Asian investment?
Joined Plenary – Navigating the path to commercialisation of ATMPs in Europe: funding, patient access and pricing and reimbursement
- European vs US investment. Should biotech strategies change depending on the region they are seeking investment?
- Recognising a gem in a crowded market. What do you look for in a biotech when investing in ATMP’s?
- Constructing mutually beneficial partnership strategies between investors and biotechs
- What’s the next big investment opportunity in ATMPs?
- How can you make your organisation more appealing to investors
- How soon is too soon for an IPO?